title: Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease.
abstract: The present study reports on the clinical outcome of 31 consecutive patients with left main coronary artery disease treated with a sirolimus-eluting stent. The implantation of this stent was associated with abolition of post-discharge fatal events and percutaneous reintervention.
authors.affiliation: Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
authors.forename: Chourmouzios A
authors.initials: CA
authors.lastname: Arampatzis
authors.forename: Pedro A
authors.initials: PA
authors.lastname: Lemos
authors.forename: Kengo
authors.initials: K
authors.lastname: Tanabe
authors.forename: Angela
authors.initials: A
authors.lastname: Hoye
authors.forename: Muzzafer
authors.initials: M
authors.lastname: Degertekin
authors.forename: Francesco
authors.initials: F
authors.lastname: Saia
authors.forename: Chi-hang
authors.initials: CH
authors.lastname: Lee
authors.forename: Arno
authors.initials: A
authors.lastname: Ruiter
authors.forename: Eugene
authors.initials: E
authors.lastname: McFadden
authors.forename: George
authors.initials: G
authors.lastname: Sianos
authors.forename: Pieter C
authors.initials: PC
authors.lastname: Smits
authors.forename: Willem J
authors.initials: WJ
authors.lastname: van der Giessen
authors.forename: Pim
authors.initials: P
authors.lastname: de Feijter
authors.forename: Ron
authors.initials: R
authors.lastname: van Domburg
authors.forename: Patrick W
authors.initials: PW
authors.lastname: Serruys
mesh_terms: D000368:Aged; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000379:methods*; D003324:Coronary Artery Disease / Q000628:therapy*; D004343:Drug Implants; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000601:surgery; D011183:Postoperative Complications / Q000209:etiology; D012086:Reoperation; D020123:Sirolimus / Q000627:therapeutic use*; D015607:Stents; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D004343:Drug Implants; D007166:Immunosuppressive Agents; D020123:Sirolimus